Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07850466 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

TRPTI Metabolic and GLP-1 Pharmacodynamic Study

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
RDC Clinical Pty Ltd
19 trials monitored
See 2 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
The goal of this clinical trial is to assess whether TRPTI™ supplementation affects GLP-1 and related metabolic markers in generally healthy adults who are overweight or obese (BMI 25.0-34.9 kg/m², aged 30 years and older). Researchers will compare TRPTI™ 150 mg to a matching placebo capsule to see if TRPTI™ produces a meaningful difference in GLP-1 response and associated metabolic and appetite-related markers over 8 hours. Participants will attend two 9-hour clinic visits (crossover design, with a minimum 6-day washout between visits).
Trial Details
NCT Number NCT07850466
Lead Sponsor RDC Clinical Pty Ltd
Collaborators: Gencor Pacific Limited, Hong Kong
Conditions
(from sponsor)		 Overweight , Obesity
Related terms Obesity, Overweight
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov